SCHEMBL6153526

SCHEMBL6153526

O=C(N[C@H]1CN2CCC1CC2)/C(F)=C/c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRNA7 P36544 5/20 0.56
CHRM2 P08172 5/20 0.53
CHRM1 P11229 5/20 0.53
CHRM3 P20309 5/20 0.53
ADRA2A P08913 2/20 0.49
ADRA2B P18089 2/20 0.49
HTR2A P28223 2/20 0.49
HTR2C P28335 2/20 0.49
HTR4 Q13639 2/20 0.49
CYP1A2 P05177 1/20 0.49
CHRM4 P08173 1/20 0.49
CYP2D6 P10635 1/20 0.49
CYP2C9 P11712 1/20 0.49
ALOX15 P16050 1/20 0.49
HTR1D P28221 1/20 0.49
ADRA1A P35348 1/20 0.49
ADRA1B P35368 1/20 0.49
HTR3E A5X5Y0 3/20 0.48
HTR3B O95264 3/20 0.48
HTR3A P46098 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6153100 1.00 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL5987553 1.00 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL5987548 1.00 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL5987731 0.85 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL6153270 0.85 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL6152549 0.85 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL6153344 0.85 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL6153268 0.85 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL6152547 0.85 CHRNA7 (0.56) CHRNA7CHRM2CHRM1CHRM3ADRA2A
SCHEMBL5987416 0.84 CHRNA7 (0.59) CHRNA7CHRM2CHRM1CHRM3ADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1233964-B1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-22 EP claimed
EP-1551832-A1 8-AZABICYCLO[3.2.1]OCTANE ETHER DERIVATIVES AND THEIR USE AS NEUROKININ RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LTD. (GB) 2005-07-13 EP disclosed
EP-1233964-B1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2005-06-22 EP disclosed
WO-2004031185-A1 8-AZABICYCLO[3.2.1]OCTANE ETHER DERIVATIVES AND THEIR USE AS NEUROKININ RECEPTOR ANTAGONISTS MERCK SHARP & DOHME LIMITED (GB) 2004-04-15 WO disclosed
US-6683090-B1 N-(1-AZABICYCLO(2.2.2)OCT-3-YL)PROPENAMIDE DERIVATIVES; PSYCHOTIC AND INTELLECTUAL IMPAIRMENT DISORDERS ASTRAZENECA AB (SE) 2004-01-27 US disclosed
EP-1233964-A1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES AstraZeneca AB (SE) 2002-08-28 EP disclosed
WO-2001036417-A1 NEW USE AND NOVEL N-AZABICYCLO-AMIDE DERIVATIVES ASTRAZENECA AB (SE) 2001-05-25 WO disclosed